Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells

Podocalyxin (PCLP1) is a CD34-related sialomucin expressed by some normal cells and a variety of malignant tumors, including leukemia, and associated with the most aggressive cancers and poor clinical outcome. PCLP1 increases breast tumor growth, migration and invasion; however, its role in hematolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamayo-Orbegozo, Estíbaliz, Amo, Laura, Riñón, Marta, Nieto, Naiara, Amutio, Elena, Maruri, Natalia, Solaun, Miren, Arrieta, Arantza, Larrucea, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725127/
https://www.ncbi.nlm.nih.gov/pubmed/29245936
http://dx.doi.org/10.18632/oncotarget.21283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725127/
https://www.ncbi.nlm.nih.gov/pubmed/29245936
http://dx.doi.org/10.18632/oncotarget.21283

Ejemplares similares